Tr Biofab Co Stock Price To Book
| 246710 Stock | KRW 5,330 90.00 1.72% |
TR Biofab Co fundamentals help investors to digest information that contributes to TR Biofab's financial success or failures. It also enables traders to predict the movement of 246710 Stock. The fundamental analysis module provides a way to measure TR Biofab's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TR Biofab stock.
246710 |
TR Biofab Co Company Price To Book Analysis
TR Biofab's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, TR Biofab Co has a Price To Book of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Health Care Equipment & Supplies (which currently averages 0.0) industry. The price to book for all Republic of Korea stocks is 100.0% higher than that of the company.
246710 Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TR Biofab's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TR Biofab could also be used in its relative valuation, which is a method of valuing TR Biofab by comparing valuation metrics of similar companies.TR Biofab is currently under evaluation in price to book category among its peers.
246710 Fundamentals
| Return On Equity | -36.36 | |||
| Return On Asset | -0.098 | |||
| Profit Margin | (0.85) % | |||
| Operating Margin | (0.86) % | |||
| Current Valuation | 534.22 B | |||
| Shares Outstanding | 8.34 M | |||
| Shares Owned By Insiders | 31.92 % | |||
| Shares Owned By Institutions | 15.60 % | |||
| Price To Sales | 70.20 X | |||
| Revenue | 3.23 B | |||
| Gross Profit | 2.64 B | |||
| EBITDA | (4.53 B) | |||
| Net Income | (11.08 B) | |||
| Cash And Equivalents | 23.66 B | |||
| Total Debt | 29.81 B | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 19.15 X | |||
| Cash Flow From Operations | (7.56 B) | |||
| Beta | 0.48 | |||
| Market Capitalization | 101.49 B | |||
| Total Asset | 82.23 B | |||
| Z Score | 1.8 | |||
| Net Asset | 82.23 B |
About TR Biofab Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TR Biofab Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TR Biofab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TR Biofab Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with TR Biofab
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TR Biofab position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TR Biofab will appreciate offsetting losses from the drop in the long position's value.Moving together with 246710 Stock
Moving against 246710 Stock
The ability to find closely correlated positions to TR Biofab could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TR Biofab when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TR Biofab - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TR Biofab Co to buy it.
The correlation of TR Biofab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TR Biofab moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TR Biofab moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TR Biofab can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 246710 Stock
TR Biofab financial ratios help investors to determine whether 246710 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 246710 with respect to the benefits of owning TR Biofab security.